解决心力衰竭中未满足的需求与保存的喷射分数:多omics方法治疗发现的方法
Taemin Kim1, Michael Sheen1, Daniel Ryan1
1Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
International journal of molecular sciences
|January 28, 2026
概括
保存喷射分数 (HFpEF) 的心力衰竭是复杂而异质的. 新的多omics方法提供精密心脏病学,以匹配与分子定义的HFpEF内型的疗法,以获得更好的结果.
科学领域:
- 心脏病学 心脏病学
- 系统生物学 系统生物学
- 精准医学是一门精准的医学.
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭影响了半数心力衰竭患者,通常与衰老,肥胖和糖尿病有关.
- 由于HFpEF的异质性,存在有限的疾病修饰疗法,包括炎症性,纤维性和心脏代谢性内啡型.
- 传统的指标不完全捕捉HFpEF的复杂性,这有助于在过去的试验中获得中立的结果.
研究的目的:
- 描述HFpEF内型和多器官相互作用.
- 批判性地评估HFpEF试验中的诊断和招生策略.
- 提出一个整合性系统生物学框架,用于HFpEF中的精密心脏病学.
主要方法:
- 对HFpEF的临床,机械和试验数据的综合.
- 对新兴的心血管多组学研究的审查.
- 开发一个系统生物学框架,用于多学科整合,生物标志物发现和目标提名.
主要成果:
- HFpEF包括重叠的内类型,具有复杂的多器官相互作用.
- 传统的诊断和试验策略导致了中立的结果.
- 新兴的多学科研究揭示了HFpEF异质性背后的分子程序.
结论:
- 综合系统生物学框架可以将分子程序与循环标记和疗法联系起来.
- 人工智能支持的多学科整合和内型丰富试验是HFpEF的未来方向.
- 精密心脏病学将治疗方法与分子定义的HFpEF内型相匹配是必不可少的.
相关概念视频
01:29Heart Failure II: Pathophysiology
872
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
872
01:17Pathophysiology of Heart Failure
3.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
01:27Heart Failure I: Introduction
847
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
847
01:22Heart Failure VI: Adjunct Therapies
314
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
314
01:22Heart Failure Drugs: Diuretics
948
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
948
01:30Heart Failure V: Medical Management
272
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
272